Page last updated: 2024-09-02

schizandrin b and daidzin

schizandrin b has been researched along with daidzin in 2 studies

Compound Research Comparison

Studies
(schizandrin b)
Trials
(schizandrin b)
Recent Studies (post-2010)
(schizandrin b)
Studies
(daidzin)
Trials
(daidzin)
Recent Studies (post-2010) (daidzin)
32112182266105
9072266105

Protein Interaction Comparison

ProteinTaxonomyschizandrin b (IC50)daidzin (IC50)
Chain A, Aldehyde Dehydrogenase, MitochondrialHomo sapiens (human)0.08
Retinal dehydrogenase 2Homo sapiens (human)4.5
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)1.2067
Aldehyde dehydrogenase X, mitochondrialHomo sapiens (human)5.1

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ahn, SJ; In, S; Kim, E; Kim, HJ; Lee, A; Min, SS1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

2 other study(ies) available for schizandrin b and daidzin

ArticleYear
Determination of 12 herbal compounds for estimating the presence of Angelica Gigas Root, Cornus Fruit, Licorice Root, Pueraria Root, and Schisandra Fruit in foods by LC-MS/MS.
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2020, Volume: 37, Issue:9

    Topics: Benzopyrans; Butyrates; Chromatography, Liquid; Coumarins; Cyclooctanes; Dioxoles; Flavanones; Food Analysis; Fruit; Glucosides; Glycosides; Glycyrrhizic Acid; Herbal Medicine; Iridoids; Isoflavones; Lignans; Plant Roots; Plants, Medicinal; Polycyclic Compounds; Tandem Mass Spectrometry

2020
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012